Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03870295
Other study ID # 2018-CHITS-03
Secondary ID 2018-A02621-54
Status Completed
Phase N/A
First received
Last updated
Start date September 30, 2019
Est. completion date September 29, 2020

Study information

Verified date October 2022
Source Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Peripheral nerve diseases can separately affect different kind of nerve fibres. Globally two kinds of fibres can be distinguished: large size and small size. The usual electromyogram only investigates large size fibres. Techniques to explore small size fibre function exist but are not used in common practice because of their very specialized aspect or their lack of diagnostic value. The purpose of this study is to develop a measurement technique of small size type C nerve fibre conduction velocity, to show that this velocity is reduced in patients suffering from polyneuropathies and to establish reference values in healthy patients.


Description:

Sympathetic skin response (SSR) is one of the simplest means to register the electrophysiological activity of small size nerve fibres. It corresponds to the emission of an electrical potential by sweat glands due to stimulation by type C nerve fibres. These fibres belong to vegetative and somatic nervous systems which can be activated by various stimuli. Medical applications were considered in the context of polyneuropathies with dysautonomia but SSR did not yield a satisfactory diagnostic value. Parameters used were SSR latency and amplitude. Latency showed little variation with pathology and it is considered that as long as fibres are present their conduction velocity is respected as an all-or-nothing phenomenon. On the contrary, amplitude is very variable, in particular between subjects, which prevents from applying a confidence interval to a given subject. Only unilateral suppression of the response seems to be a reliable criterion and gave results in the context of peripheral nervous pathologies. The good results obtained with "response suppression" shows SSR sensibility. The discredit of "conduction velocity" variable seems to come from a publication using microneurography. However with this technique only one fascicle is investigated and preferably one giving a good signal, so not representative of all nerve fibres. Consistent results were achieved with a technique consisting in recording SSR at two points of a same path, separated by a known distance. Knowing the difference of response latency at these two points, velocity could be deduced on the path. This technique was tested in healthy patients in 1988 taking as measurement sites the hand stuck on the body and the ground as a reference for foot plantar. It gave a velocity equivalent to the result found by another team with the same method. The purpose of the study is to apply this technique to pathology. It should be noted that the velocity measured in this way depends on superior and inferior limb paths, on a medullar portion between C7 et D12 and on pre-ganglionic neurone portion. It has consequently no lesion focalisation capacities and is more appropriate for polyneuropathies with diffuse damage. Nevertheless, it has two advantages. First sweet follicles are in the same functional state in hand and on foot since stimulation intervals are the same at both levels. Secondly the influence of cerebral trunk centres on SSR emission and latency may be bypassed. Thus the study hypothesis is that conduction velocity determination of SSR constituting fibres will better characterize their functional state than response latency measurement which is subject to central excitability variations.


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date September 29, 2020
Est. primary completion date September 29, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria for experimental group: - Patients with polyneuropathy explicit suspicion or whose symptomatology evokes this disease confirmed by electromyogram - Free informed consent of patient Inclusion Criteria for control group: - Patients having a consultation scheduled in neurology department - Free informed consent of patient Exclusion Criteria for experimental group: - Age < 18 years old - Signs or medical history of central nervous system damage - Person suffering from another peripheral nervous system pathology than polyneuropathy - Known or suspected pregnancy and breastfeeding women - Patients not covered by a social security regimen - Patients under legal guardianship - Patients deprived of their liberty due to judicial or administrative decision Exclusion Criteria for control group: - Age < 18 years old - Polyneuropathy suspicion - Signs or medical history of peripheral or central nervous system damage - Known or suspected pregnancy and breastfeeding women - Patients not covered by a social security regimen - Patients under legal guardianship - Patients deprived of their liberty due to judicial or administrative decision

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Sympathetic skin response (SSR) measure
Ankle - ground distance measurement, hand and foot cutaneous temperature reading, low intensity electrical stimulations on hand and on foot to determine SSR at these two points and DN4 questionnaire to assess the possible presence of neuropathic pain

Locations

Country Name City State
France Centre hospitalier intercommunal de Toulon La Seyne sur Mer Toulon

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer

Country where clinical trial is conducted

France, 

References & Publications (14)

Arunodaya GR, Taly AB, Swamy HS. Sympathetic skin response in acute sensory ataxic neuropathy. J Neurol Sci. 1995 May;130(1):35-8. — View Citation

Carmichael EA, Honeyman WM, Kolb LC, Stewart WK. Peripheral conduction rate in the sympathetic nervous system of man. J Physiol. 1941 Mar 25;99(3):338-43. — View Citation

Elie B, Guiheneuc P. Sympathetic skin response: normal results in different experimental conditions. Electroencephalogr Clin Neurophysiol. 1990 Sep;76(3):258-67. — View Citation

Fagius J, Wallin BG. Sympathetic reflex latencies and conduction velocities in normal man. J Neurol Sci. 1980 Sep;47(3):433-48. — View Citation

Fagius J, Wallin BG. Sympathetic reflex latencies and conduction velocities in patients with polyneuropathy. J Neurol Sci. 1980 Sep;47(3):449-61. — View Citation

Knezevic W, Bajada S. Peripheral autonomic surface potential. A quantitative technique for recording sympathetic conduction in man. J Neurol Sci. 1985 Feb;67(2):239-51. — View Citation

Montagna P, Marchello L, Plasmati R, Ferlini A, Patrosso MC, Salvi F. Electromyographic findings in transthyretin (TTR)-related familial amyloid polyneuropathy (FAP). Electroencephalogr Clin Neurophysiol. 1996 Oct;101(5):423-30. — View Citation

Sequeira H, Hot P, Silvert L, Delplanque S. Electrical autonomic correlates of emotion. Int J Psychophysiol. 2009 Jan;71(1):50-6. doi: 10.1016/j.ijpsycho.2008.07.009. Epub 2008 Jul 23. Review. — View Citation

Soliven B, Maselli R, Jaspan J, Green A, Graziano H, Petersen M, Spire JP. Sympathetic skin response in diabetic neuropathy. Muscle Nerve. 1987 Oct;10(8):711-6. — View Citation

Sourek K. [Reflex skin potential reactions in cases of surgically tested discopathies]. Acta Univ Carol Med (Praha). 1965:Suppl 21:99+. Multiple languages. — View Citation

Tzeng SS, Wu ZA, Chu FL. The latencies of sympathetic skin responses. Eur Neurol. 1993;33(1):65-8. — View Citation

Uncini A, Pullman SL, Lovelace RE, Gambi D. The sympathetic skin response: normal values, elucidation of afferent components and application limits. J Neurol Sci. 1988 Nov;87(2-3):299-306. — View Citation

Valls-Sole J, Monforte R, Estruch R. Abnormal sympathetic skin response in alcoholic subjects. J Neurol Sci. 1991 Apr;102(2):233-7. — View Citation

Vetrugno R, Liguori R, Cortelli P, Montagna P. Sympathetic skin response: basic mechanisms and clinical applications. Clin Auton Res. 2003 Aug;13(4):256-70. Review. — View Citation

* Note: There are 14 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Measurement of sudomotor fibre conduction velocity Sudomotor fibre conduction velocity measurement and comparison between patients suffering from polyneuropathy and control patients 30 minutes
Secondary Link between neuropathic pain and conduction velocity Correlation between DN4 questionnaire score and conduction velocity 30 minutes
See also
  Status Clinical Trial Phase
Completed NCT02552277 - A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy Phase 2
Completed NCT05133947 - Pre-study to Evaluate IENFD Induction in Patients With Taxane-induced CIPN
Recruiting NCT04800484 - The Effects of AFO Heel Height and Stiffness on Gait N/A
Completed NCT01465620 - Dietetic and Hygiene Measures in Metabolic Neuropathies: the Neurodiet Study Phase 3
Recruiting NCT06407154 - Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study, 2nd Wave
Not yet recruiting NCT05777499 - MUSic Therapy In Complex Specialist Neurorehabilitation N/A
Completed NCT01954199 - The Effectiveness of Neurodynamic Techniques in Patients With Nerve-Related Leg Pain N/A
Completed NCT00300222 - Study of NGX-4010 for the Treatment of Postherpetic Neuralgia Phase 3
Completed NCT00034710 - Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain Phase 2
Recruiting NCT04014244 - Dextrose, Corticosteroids and Surgical Release in Carpal Tunnel Syndrome N/A
Recruiting NCT03913689 - StimRouter Registry Clinical Protocol
Completed NCT02654691 - Chronic Neuropathy Following Chemotherapy
Completed NCT00321672 - Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy Phase 3
Completed NCT00115310 - Study of NGX-4010 for the Treatment of Postherpetic Neuralgia Phase 3
Not yet recruiting NCT03530592 - Seated Ankle Robot for Foot Drop in Aging and Disabled Populations: A Demonstration Project N/A
Completed NCT02115932 - Effect of Physical Therapy in Improving the Health of Patients With Diabetic Peripheral Neuropathy N/A
Terminated NCT05961163 - Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study
Terminated NCT00832572 - Study of Ranexa in Patients With Coronary Artery Disease and Painful Polyneuropathy Phase 4
Completed NCT00270842 - Effect of Exercise on Gait and Balance in Peripheral Neuropathy N/A
Completed NCT00046722 - Marijuana for HIV-Related Peripheral Neuropathy Phase 1/Phase 2